Everything we carry.

A 15-amino-acid fragment of a gastric protein, widely studied for tendon, ligament, muscle and gut-lining repair and for supporting new blood-vessel growth at injury sites.

A synthetic fragment of Thymosin Beta-4. Research focuses on cell migration, flexibility of healing tissue and reduced inflammation after injury.

A tripeptide derived from alpha-MSH, studied for calming inflammatory signaling, particularly in the gut and skin.

An erythropoietin-derived peptide studied for nerve protection and neuropathic discomfort, without EPO's effects on red blood cells.

BPC-157 10mg + TB-500 10mg

The classic repair pairing of BPC-157 and TB-500 in one vial, combining localized and systemic tissue-repair research.

BPC-157 10mg + TB-500 10mg + KPV 10mg

The Wolverine pairing with added KPV for researchers studying repair alongside inflammation control.

BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg

BPC-157, TB-500 and GHK-Cu combined, studied for tissue repair together with collagen and skin remodeling.

GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg

The Glow blend plus KPV — a four-peptide stack covering repair, collagen support and inflammation.

A GHRH analog studied for raising natural growth hormone output, with research focused on reducing visceral (abdominal) fat.

A GHRH analog studied for raising natural growth hormone output, with research focused on reducing visceral (abdominal) fat.

A GHRH analog studied for raising natural growth hormone output, with research focused on reducing visceral (abdominal) fat.

A GHRH analog paired with a selective GH secretagogue to study a stronger, more natural growth hormone pulse.

CJC-1295 (no DAC) 5mg + Ipamorelin 5mg

The most widely studied GH pairing: CJC-1295 extends the signal while Ipamorelin triggers a clean GH release.

Also called Mod GRF 1-29. A short-acting GHRH analog that produces natural, pulse-like growth hormone release.

A long-acting GHRH analog bound to albumin, studied for sustained elevation of growth hormone and IGF-1 over days.

A selective ghrelin-receptor agonist studied for clean GH release with minimal effect on cortisol or appetite.

One of the earliest GHRH analogs, studied for restoring natural growth hormone rhythms, often linked to sleep and recovery.

A long-acting form of insulin-like growth factor 1, studied for muscle cell growth and recovery downstream of growth hormone.

A GLP-1 receptor agonist studied for appetite reduction, slower gastric emptying and improved blood-sugar control.

A dual GIP / GLP-1 agonist. In research it has shown greater weight reduction than GLP-1 alone, alongside metabolic improvements.

A dual GIP / GLP-1 agonist. In research it has shown greater weight reduction than GLP-1 alone, alongside metabolic improvements.

A dual GIP / GLP-1 agonist. In research it has shown greater weight reduction than GLP-1 alone, alongside metabolic improvements.

A dual GIP / GLP-1 agonist. In research it has shown greater weight reduction than GLP-1 alone, alongside metabolic improvements.

A triple agonist (GIP, GLP-1 and glucagon receptors) and one of the most potent weight-loss compounds in current trials.

A triple agonist (GIP, GLP-1 and glucagon receptors) and one of the most potent weight-loss compounds in current trials.

A triple agonist (GIP, GLP-1 and glucagon receptors) and one of the most potent weight-loss compounds in current trials.

A long-acting amylin analog studied for fullness and appetite control, often researched alongside GLP-1 agonists.

A triple incretin agonist combined with an amylin analog, studied for complementary effects on appetite and energy balance.

A small molecule that blocks the NNMT enzyme, studied for raising cellular NAD+ and reducing fat-cell growth.

A coenzyme central to cellular energy and DNA repair. Levels decline with age, making it a core longevity research compound.

A coenzyme central to cellular energy and DNA repair. Levels decline with age, making it a core longevity research compound.

A peptide encoded in mitochondrial DNA, studied for insulin sensitivity, metabolic flexibility and exercise capacity.

A peptide encoded in mitochondrial DNA, studied for insulin sensitivity, metabolic flexibility and exercise capacity.

Also known as Elamipretide. Targets the inner mitochondrial membrane and is studied for protecting cellular energy production.

Also known as Elamipretide. Targets the inner mitochondrial membrane and is studied for protecting cellular energy production.

A synthetic tetrapeptide studied for telomerase activation, circadian rhythm and markers of cellular aging.

A synthetic ACTH-derived peptide studied for focus, memory and nerve-growth-factor (BDNF) signaling.

A tuftsin analog studied for reducing anxiety and supporting calm focus without sedation.

A short tripeptide studied for supporting brain cells, sleep regulation and cognitive aging.

Delta Sleep-Inducing Peptide, studied for promoting deep, slow-wave sleep and regulating stress hormones.

Bremelanotide, a melanocortin agonist that acts on the brain and is studied for sexual arousal in both men and women.

A hormone signal studied for triggering the body's natural LH and testosterone production and reproductive function.

A copper-binding peptide found naturally in the body, studied for collagen production, skin firmness, wound healing and hair.

A copper-binding peptide found naturally in the body, studied for collagen production, skin firmness, wound healing and hair.

A melanocortin analog studied for skin pigmentation (tanning) with less sun exposure; also studied for libido.

A thymus-derived peptide studied for strengthening immune response and immune balance.

Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilized peptides for laboratory use.